what companies make glp 1 drugs Asia-Pacific Glucagon-like Peptide-1 (GLP-1) Agonists The Biggest Winner of GLP-1

Many of these emerging players are based in China, indicating a potential shift in market dynamics unless major licensing or acquisition deals occur

During the insurers April 30 earnings call, President and Chief Operating Officer Brian Evanko , who is set to become CEO on July 1, said the percentage of clients covering weight management medications has remained relatively stable from 2025 to 2026

Recent reviews note the need for careful monitoring of cardiometabolic effects, particularly since long-term safety data in adolescents are still emerging

Analyst Opinion Sabyasachi Ghosh, Principal Consultant for Healthcare at FMI, suggests, The GLP-1 receptor agonist market is expected to shift toward companies able to combine clinical evidence with reliable supply execution

Lei WS, Kilberg MJ, Zemel BS, et al

This large pack format provides a high-quality collagen supplement at great value